Drug hope for Crohn's patients: New treatment is first to work in the gut to target symptoms on the disease
Vedolizumab is the first to work directly in the gut lining, targeting the inflammation that causes chronic symptoms such as diarrhoea, bleeding and fatigue. Daily Mail
No comments:
Post a Comment